Sector portfolio · Corporate investor · United States

Google Ventures' Biotech portfolio

Google Ventures has backed 74 Biotech startups in rounds we track, $12B between them, shown by the stage each has reached. The best-funded is Relay Therapeutics.

74startups backed
4stages
$12Braised between them
Series C and laterbiggest stage

Google Ventures's whole portfolioGoogle Ventures's profile

Series C and later

25

+1 more

Series B

17

Series A

16

Stage not reported

16

Segment by segment

Series C and later

25 startups · $4.7B raised

  1. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  2. 23andMeUnited States$729M
  3. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  4. LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
  5. AlectorAlector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases.United States$215M
  6. Spero TherapeuticsSpero Therapeutics develops therapeutics for treatment of gram-negative infections.United States$199M
  7. Decibel TherapeuticsDecibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.United States$189M
  8. DNAnexusDNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery.United States$173M

Series B

17 startups · $2.4B raised

  1. Denali TherapeuticsDenali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.United States$547M
  2. Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
  3. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  4. Tenaya TherapeuticsTenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.United States$152M
  5. Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
  6. EpiBiologicsEpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022.United States$107M
  7. ContralineContraline is a clinical-stage biotechnology company based in Charlottesville, Virginia, founded in 2015.United States$100M
  8. IIdeayaUnited States$94M

Series A

16 startups · $1.4B raised

  1. Tome BiosciencesTome Biosciences is a biotechnology company based in Watertown, MA, focused on advancing programmable genomic integration (PGI) toUnited States$213M
  2. Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
  3. Bitterroot BioBitterroot Bio, Inc.United States$145M
  4. Kronos BioKronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.United States$123M
  5. Merida BiosciencesMerida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autUnited States$121M
  6. RhygazeRhyGaze is a biotechnology company based in Basel, Switzerland, and Philadelphia, Pennsylvania, founded in 2024.Switzerland$86M
  7. IconOVir BioIconOVir Bio is a biotechnology company based in San Diego, California, founded in 2018.United States$77M
  8. Areteia TherapeuticsAreteia Therapeutics, Inc.United States$75M

Stage not reported

16 startups · $3.4B raised

  1. NeuralinkNeuralink develops a brain machine interface that provides solutions for those with paralysis.United States$882M
  2. IDEAYA BiosciencesIDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.United States$608M
  3. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  4. Vera TherapeuticsVera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.United States$261M
  5. Leyden LabsLeyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions foNetherlands$221M
  6. SchrödingerSchrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotecUnited States$195M
  7. Vir BiotechnologyVir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.United States$150M
  8. ABARMO BioSciencesARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.United States$117M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Google Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioGoogle Ventures' AI portfolio81 startups · $16BSector portfolioGoogle Ventures' IT Services portfolio32 startups · $2.9BSector portfolioGoogle Ventures' Big Data & Analytics portfolio30 startups · $2.1BSector portfolioGoogle Ventures' Internet portfolio27 startups · $2.5BSector portfolioGoogle Ventures' Healthtech portfolio24 startups · $3.9BSector portfolioGoogle Ventures' Fintech portfolio22 startups · $13B

Raising from investors like Google Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps